Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Incidence of anaphylactoid reactions to isosulfan blue dye reviewed
October 6th, 2005
Scientists reviewed the incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping. According to a study from the United States, "Severe anaphylactoid reactions to isosulfan blue dye requiring resuscitation are reported to occur in 1.1% of patients with breast carcinoma undergoing sentinel lymphadenectomy. In December 2001, the authors began administering a prophylactic regimen before dye injection to determine whether prophylaxis reduced the incidence of life-threatening reactions." "All patients were mapped with technetium-99m-labeled sulfur colloid. Those also receiving isosulfan blue dye were administered...
Source: Women's Health Weekly (2005-10-06)
|
